We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Glucose in Hospitalized Patients Predicts Diabetes Risk

By LabMedica International staff writers
Posted on 03 Sep 2014
Blood glucose levels measured in hospitalized adults during acute illness can be used to predict the risk of developing type 2 diabetes over the following three years. More...


Many patients admitted to hospital because of an acute illness have hyperglycemia, an abnormally high blood glucose level which can be caused by the drugs that patients are taking for existing conditions or may be stress hyperglycemia.

Scientists at the University of Edinburgh (UK) carried out a retrospective cohort study on patients aged 30 years or older with an emergency admission to hospital between 2004 and 2008. They obtained measurements of blood glucose levels on admission for 86,634 patients who were admitted to a hospital for an acute illness and identified those patients who developed type 2 diabetes up to December 2011.

The investigators found that the overall three year risk of developing type 2 diabetes was 2.3%, with the risk of developing diabetes increased linearly with increasing blood glucose level at admission. The three year risk of type 2 diabetes was 1% for patients with a glucose level of less than 5 mmol/L (90 mg/dL) and increased to approximately 15% for patients with glucose of 15 mmol/L (270 mg/dL) or more. The team developed a risk calculator that uses the patient's age, sex, and admission blood glucose level to predict risk of developing diabetes over three years following hospital admission.

The scientists confirm that single measures using the WHO cut-points for diagnosing diabetes, which are not based upon studies that measured glucose in the emergency setting cannot be directly applied in acutely unwell patients with hyperglycemia. They found that 90% of patients with admission glucose of 11.1 mmol/L (200 mg/dL) were not diagnosed with diabetes within three years of discharge from the hospital.

The authors conclude that the three year risk of type 2 diabetes was less than 1% for patients with a glucose of less than or equal to 5 mmol/L and increased linearly to approximately 15% at 15 mmol/L, above which there was no further increase in risk. Mortality was also 1.5-fold higher in patients with glucose levels of 11.1 to 15 mmol/L compared to those with glucose levels less than 6.1 mmol/L. These findings can be used to inform individual patients of their long-term risk of type 2 diabetes and to offer lifestyle advice as appropriate. The study was published on August 19, 2014, in the journal Public Library of Science Medicine.

Related Links:

University of Edinburgh



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Host Response Immunoassay Test
MeMed BV
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.